IA
CORT icon

Investor AB’s Corcept Therapeutics CORT Stock Holding History

Investor AB’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-750,423
Closed -$14.5M – 9
2017
Q3 		$14.5M Hold
750,423
– – 0.93% 3
2017
Q2 		$8.86M Hold
750,423
– – 0.62% 3
2017
Q1 		$8.22M Sell
750,423
-624,999
-45% -$5.49M 0.59% 4
2016
Q4 		$9.99M Sell
1,375,422
-460,552
-25% -$3.61M 0.73% 5
2016
Q3 		$11.9M Hold
1,835,974
– – 0.86% 3
2016
Q2 		$10M Hold
1,835,974
– – 0.75% 6
2016
Q1 		$8.59M Buy
1,835,974
+4,294
+0.2% +$16.7K 0.63% 6
2015
Q4 		$9.12M Hold
1,831,680
– – 0.74% 6
2015
Q3 		$6.89M Buy
1,831,680
+84,360
+5% +$428K 0.61% 6
2015
Q2 		$10.5M Sell
1,747,320
-1,342,185
-43% -$8.23M 0.98% 6
2015
Q1 		$17.3M Sell
3,089,505
-365,240
-11% -$1.32M 1.55% 5
2014
Q4 		$10.4M Hold
3,454,745
– – 1% 6
2014
Q3 		$9.26M Hold
3,454,745
– – 0.98% 6
2014
Q2 		$9.67M Hold
3,454,745
– – 1.1% 6
2014
Q1 		$15.1M Hold
3,454,745
– – 1.77% 5
2013
Q4 		$11.1M Hold
3,454,745
– – 1.28% 5
2013
Q3 		$5.53M Hold
3,454,745
– – 0.64% 7
2013
Q2 		$5.98M Buy
+3,454,745
New +$6.21M 0.7% 9

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Investor AB's CORT Position: Q4 2017 in Review

Investor AB sold out of Corcept Therapeutics (CORT) in Q4 2017, closing a stake of 750,423 shares — an estimated $14.5M sold.

Investor AB first reported a position in CORT in Q2 2013 and held it in 18 quarters. The position peaked at $17.3M in Q1 2015. 190 funds tracked by Wall St. Rank hold CORT as of Q4 2017.

  • Investor AB reported no remaining Corcept Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Investor AB sold 750,423 Corcept Therapeutics shares in Q4 2017, an estimated $14.5M.
  • Investor AB first reported a position in Corcept Therapeutics in Q2 2013 and held it in 18 quarters.
  • Investor AB's Corcept Therapeutics position peaked at $17.3M in Q1 2015.
  • 190 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2017.

Based on Investor AB's 13F filing for Q4 2017, filed 14 Feb 2018.